e-learning
resources
Barcelona 2010
Monday, 20.09.2010
New mechanisms in lung development, acute and chronic lung diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
LSC 2010 Abstract: Systemic elastin degradation in COPD
J. Maclay, R. Rabinovich, D. McAllister, S. Hartland, M. Mathers, S. Maxwell, R. Weller, N. Mills, W. MacNee (Edinburgh, United Kingdom)
Source:
Annual Congress 2010 - New mechanisms in lung development, acute and chronic lung diseases
Session:
New mechanisms in lung development, acute and chronic lung diseases
Session type:
E-Communication Session
Number:
2205
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Maclay, R. Rabinovich, D. McAllister, S. Hartland, M. Mathers, S. Maxwell, R. Weller, N. Mills, W. MacNee (Edinburgh, United Kingdom). LSC 2010 Abstract: Systemic elastin degradation in COPD. Eur Respir J 2010; 36: Suppl. 54, 2205
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
LSC 2011 Abstract: Role of mast cells and chymase in idiopathic pulmonary fibrosis
Source: Annual Congress 2011 - Experimental models and research in diffuse parenchymal lung diseases
Year: 2011
LSC 2010 Abstract: Overexpression of Ang-(1-7)-fusion protein in the lungs prevents pulmonary fibrosis and accompanying pulmonary hypertension
Source: Annual Congress 2010 - Pre-clinical models of airways disease
Year: 2010
LSC 2010 Abstract: Dynamics of inflammation and lung functioning in murine ozone model of COPD
Source: Annual Congress 2010 - Novel mechanisms in COPD
Year: 2010
LSC 2010 Abstract: Potential of ACE2 as a therapeutic target for pulmonary hypertension
Source: Annual Congress 2010 - New mechanisms in lung development, acute and chronic lung diseases
Year: 2010
LSC 2010 Abstract: Synthetic dsRNA exacerbates pulmonary inflammation in acute and sub-chronic
in vivo
models of COPD
Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities
Year: 2010
LSC 2013 abstract - Bioavailability of VEGF in idiopathic pulmonary fibrosis
Source: Annual Congress 2013 –Growth factors at the crossroads of acute and chronic inflammation
Year: 2013
Inhibition of profibrotic signaling in fibroblasts from patients with idiopathic pulmonary fibrosis (IPF) by histone deacetylase-inhibitors (HDACi) or the IPF drug pirfenidone
Source: International Congress 2014 – ILDs 1
Year: 2014
LSC 2014 abstract - Influenza infection may cause exacerbation of lung fibrosis through collagen deposition
Source: International Congress 2014 – Pulmonary fibrosis: receptors, signalling pathways and mesenchymal cells
Year: 2014
Malanoyl dialdehyde (MDA) and hs-CRP: How are they linked to COPD?
Source: International Congress 2014 – Mechanisms of COPD and inhalation injury
Year: 2014
Vascular remodelling in COPD
Source: Lung Science Conference 2007 - Translational research in pulmonary disease: Hypoxia-driven mechanisms
Year: 2007
Systemic inflammatory markers in COPD: results from the Bergen COPD Cohort Study
Source: Eur Respir J 2010; 35: 540-548
Year: 2010
LSC 2011 Abstract: The role of lipoxin A4 in the chronic obstructive pulmonary disease
Source: Annual Congress 2011 - Recent developments in COPD
Year: 2011
LSC 2011 Abstract: Inflammation and COPD: Protective effect of the recombinant anti-protease trappin-2 A62L, on lung epithelium
Source: Annual Congress 2011 - Recent developments in COPD
Year: 2011
Altered P2 receptor expression profile in sputum cells of patients with COPD
Source: International Congress 2014 – Monitoring COPD with different biomarkers
Year: 2014
LSC 2014 abstract - Evaluation of paraoxonase1 activity and its relationship to the severity of lung impairment in COPD
Source: International Congress 2014 – Translational studies in COPD
Year: 2014
The importance of pulmonary mineralogic analysis (PMA) in interstitial lung disease (ILD). A retrospective study of 226 samples from 2005 to 2011
Source: Annual Congress 2013 –Occupational respiratory diseases: asthma, silicosis and asbestosis
Year: 2013
Surface-bound TIMP-1 on PMNs promotes pericellular proteolysis: A new culprit in COPD?
Source: International Congress 2015 – Airway remodelling: recent developments
Year: 2015
LSC 2010 Abstract: Acute lung inflammation in response to carbon nanoparticle exposure is augmented in the absence of NF-kB
Source: Annual Congress 2010 - Emerging mechanisms in lung injury
Year: 2010
Pulmonary manifestations in rheumatoid arthritis: A hospital based descriptive study
Source: International Congress 2014 – ILDs: connective tissue disease
Year: 2014
Alterations in gene expression of RAGE and its sheddases in blood of COPD patients do not relate to decreased plasma (e)sRAGE levels
Source: International Congress 2014 – Mechanisms of COPD and inhalation injury
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept